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Abstract
Objective: Body mass index (BMI) has been found to be associated with 
perimenopausal symptoms. This study focused on the relationship 
between overall perimenopausal symptoms and obesity in Taiwanese 
women living in rural communities.
Materials and Methods: This study was cross-sectional and descriptive, 
and the subjects included 56 climacteric women from a rural community 
in southern Taiwan. Data were collected using the Perceived Perimenopausal 
Disturbances Scale and face-to-face interviews, and obesity was assessed by 
anthropometric measurements (height, weight, and waist circumference).
Results: The current analysis included 56 women 40–60 years of age 
(mean age = 47.11 years). Twenty-five percent of the women were obese 
(BMI ≥ 27 kg/m2) and 39.3% presented with central obesity (waist circum-
ference ≥ 80 cm). Based on the subscale for perimenopausal symptoms, 
we found that for postmenopausal women, a higher BMI and waist cir-
cumference were associated with more frequent urinary complaints and 
reproductive system symptoms.
Conclusion: Participants reported more frequent urinary problems when 
they were postmenopausal, and these problems were associated with a 
higher BMI. The findings suggest that clinical practitioners should consider 
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1. Introduction
The onset of menopause begins between the ages of 
45 and 55 years. The process of menopause can be 
classified into three states: premenopause, perimeno-
pause, and postmenopause. Perimenopause may last 
from 2 to 8 years [1]. Menopausal transition leads to the 
presentation of a series of clinical signs and symptoms 
such as vasomotion disorders, which are caused by 
progressive estrogenic deficiency [2,3]. Both physiolog-
ical and psychosocial changes among perimenopausal 
women in Taiwan have recently been described [4,5].
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Obesity is a public health problem in many coun-
tries. Research has shown that the prevalence of ob-
esity in females is higher than in males and increases 
gradually with age, especially for women aged 40–59 
years [6,7]. Recent research has shown that obesity 
is associated with metabolic syndrome diseases. The 
causes of obesity, including being overweight and fat 
distribution changes, may be related to hormonal 
changes during the menopause transition [8,9]. In 
this regard, obesity problems in middle-aged women 
have attracted renewed attention.
Several studies have focused on the correlation be-
tween body mass index (BMI) and perimenopausal 
symptoms. A study found that women aged 40–44 
years with a high BMI tend to have a higher incidence 
of hot flashes [10]. Erlik et al, however, found that 
postmenopausal women who are below average in 
weight are more likely to have hot flashes, which are 
associated with decreasing levels of estrogen [11]. 
Another study found that BMI is unrelated to the cli-
macteric vasomotion symptoms of women [12], and it 
has been suggested that weight gain in middle-aged 
women is unrelated to the transition from pre- to peri- 
to menopause [13]. Another study found that women 
with stress urinary incontinence have a higher BMI 
[14]. Recent studies have further confirmed the pre-
viously well-known role of obesity as a risk factor for 
stress urinary incontinence [15–17]. Taken together, 
the findings of these various studies present no clear 
relationship between perimenopausal symptoms and 
BMI in mid-life women.
The most frequently reported symptoms in over-
weight or obese women in perimenopause are joint 
ache/stiffness, bone pain, paresthesia in the extremi-
ties, hot flashes, and urinary incontinence [18]. Hence, 
the present study focused on the relationship between 
overall perimenopausal symptoms and obesity in 
Taiwanese women living in rural communities who 
were engaged in farming or household work, and had 
a lower socioeconomic status. We also examined the 
relationship between perimenopausal symptoms and 
obesity, age, and menopausal transition in our sample 
of women.
Our hypotheses were as follows: (1) perimeno-
pausal symptoms, BMI, and waist circumference are 
significantly different among pre-, peri-, and post-
menopausal women; and (2) women’s BMI and waist 
circumference are significantly associated with the 
experience of perimenopausal symptoms.
2. Materials and methods
2.1. Aims
The aims of this study were to: (1) compare the wom-
en’s BMI, waist circumference, and experience with 
perimenopausal symptoms based on menopausal 
state; and (2) assess the differences in the women’s 
experience with perimenopausal symptoms based 
on BMI and waist circumference.
2.2. Design
This study was a cross-sectional descriptive survey 
adopting a questionnaire that was used to collect data 
and anthropometric measurements (height, weight, 
and waist circumference) to assess obesity in mid-
life women.
2.3. Setting
Four activity centers in a rural area of southern Taiwan 
were randomly selected for the sampling of partici-
pants. Data were collected between October 2006 and 
January 2007.
2.4. Sample
To qualify for participation, each woman needed to 
meet the following criteria: (1) aged between 40 and 
60 years of age; (2) ability to speak Mandarin or the 
Taiwanese dialect; (3) willingness to participate in a 
face-to-face interview; (4) residency in a rural area in 
southern Taiwan; and (5) not taking hormone replace-
ment drugs. The participants signed consent forms 
and agreed to provide study information. Data col-
lection methods included a face-to-face interview 
conducted to help the participant complete the ques-
tionnaire and to collect physiological data such as 
height and weight. The interview time was approxi-
mately 30 minutes.
Sixty women participated in this study; four women 
were excluded because they were taking hormone re-
placement drugs or had had a hysterectomy. Thus, a 
total of 56 women entered the study for data analysis. 
Menopausal states were defined as follows: (1) pre-
menopausal period: experiencing 12 or more regular 
menstruations during the last 12 months; (2) perimen-
opausal period: experiencing fewer than 12 irregular 
menstruations during the last 12 months; and (3) 
postmenopausal: not having menstruated for the last 
12 months [19].
2.5. Measurements
The subject data included in this study were age, 
education, employment, marriage, current state of 
menopause, menstruation, and anthropometric data. 
Anthropometric evaluation consisted of measurements 
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of height, weight, and waist circumference, which were 
obtained before the participant ate a meal. Mea-
surements were taken by the same investigator to 
minimize variability in the data. Body sites for mea-
surements were confirmed by a registered nurse who 
had received special training. Participants were 
weighed without shoes but with light indoor clothing. 
A measuring stick was used to measure the partici-
pants’ standing height without shoes. A plastic-coated 
measuring tape was used to measure the waist cir-
cumference (cm) at the end of expiration, with the 
navel as the pivot. BMI was calculated as the weight 
in kilograms divided by the square of the height in 
meters (kg/m2). We adapted the following definition 
from the Department of Health in Taiwan: women 
with a BMI ≥ 27 kg/m2 were considered obese, while 
those with a BMI < 27 kg/m2 were considered non-
obese. Central obesity in Asian and Chinese women 
is defined by a waist circumference ≥ 80 cm [20].
The Perceived Perimenopausal Disturbances Scale 
was developed by Tsao et al [21]; and the scale has 
demonstrated good validity and reliability, with a 
Cronbach’s α of 0.95. Symptoms are categorized 
across five subscales (domains): cardiovascular and 
autonomic nervous system symptoms (e.g. palpita-
tions, hot flashes, headache, dizziness, and perspi-
ration); osteoarthritis symptoms (e.g. joint pain and 
back pain); urinary system symptoms (e.g. nocturia, 
stress urinary incontinence, and micturition); repro-
ductive system symptoms (e.g. vaginal itching, vaginal 
dryness, dyspareunia, and decline in sexual interest); 
and psychological and psychiatric symptoms (e.g. fa-
tigue, depression, anxiety, insomnia, forgetfulness, in-
security, and inability to concentrate). There is a total 
of 38 questions. All questions are rated on a 4-point 
Likert-type scale (1 = not present, 2 = mild, 3 = moder-
ate, and 4 = severe). The score of each domain is the 
sum of the mean scores of the symptoms within that 
domain, and the total score is the sum of the mean 
scores of all symptoms. The symptoms become more 
obtrusive as the score increases. This scale was 
adopted to assess perimenopausal women in Taiwan, 
has been previously published [22,23], and its valid-
ity is sound. In our study, the Cronbach’s α value for 
the overall scale was 0.89.
2.6. Data analysis
Except for the descriptive statistics, analysis of cov-
ariance (ANCOVA) was used to evaluate the potential 
confounding of age in identifying differences in the 
BMI, waist circumference, and perimenopausal symp-
toms under different states of menopause. Finally, if 
the confounding variable was not significant and states 
of menopause were significant, analysis of variance 
(ANOVA) was used. We used ANOVA to compare the 
differences in perimenopausal symptom disturbance 
under different states of menopause and the Bonferroni 
test for multiple comparisons. Because the data were 
not normally distributed and the standard deviations 
were not equal, the Kruskal-Wallis test was used to 
compare differences under different states of meno-
pause, specifying BMI, and the Mann-Whitney U test 
was performed three times for multiple comparisons 
under a type I error correction. Disturbance of peri-
menopause was assessed according to the level 
of BMI and waist circumference by the Mann-Whitney 
U test.
2.7. Ethical considerations
This study was approved by the local community 
committee, and participation was voluntary. Partici-
pants were verbally invited to be involved in this study 
and gave written consent to be interviewed.
3. Results
3.1. The study population
Data from the women are shown in Table 1. A total of 
56 women between 40 and 60 years of age in south-
ern Taiwan were selected to participate in this study. 
Participants included 24 premenopausal women, 14 
perimenopausal women, and 18 postmenopausal 
women. Their mean age was 47.11 years. Most (92.9%) 
of the participants were married and 53.6% were 
Table 1 — Demographics and anthropometrics of 
women (n = 56)*
Age (yr) 47.11 ± 5.20 (40–60)
Education 
   Elementary school or below 27 (48.2)
   Junior high school 16 (28.6)
   Senior high school or above 13 (23.2)
Marital status 
   Married 52 (92.9)
   Divorced + other  4 (7.1)
Employed 
   Yes 30 (53.6)
   No 26 (46.4)
State of menopause 
   Premenopause 24 (42.5)
   Perimenopause 14 (25.0)
   Postmenopause 18 (32.1)
Body mass index 
   < 27 kg/m2 42 (75.0)
   ≥ 27 kg/m2 14 (25.0)
Waist circumference 
   < 80 cm 34 (60.7)
   ≥ 80 cm 22 (39.3)
*Data presented as mean ± standard deviation (range) or n (%).
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employed. Approximately half of the participants had 
low levels of education (48.2% were elementary school 
graduates or below). Approximately 25% of the women 
had a BMI ≥ 27 kg/m2 and 39.3% had a waist circum-
ference ≥ 80 cm.
3.2. Anthropometric measurements and 
experience with perimenopausal 
symptoms related to menopause states
Comparison of BMI and waist circumference by men-
opause stage is depicted in Table 2. In general, a 
trend towards an increase in age, level of BMI, waist 
circumference, and experience with perimenopause 
symptoms was observed from the premenopausal to 
postmenopausal states. Menopause states (pre- vs. 
peri- and postmenopausal) were significantly differen-
tiated by BMI (p < 0.017, Bonferroni type I correction: 
0.05/3 ≈ 0.017) and waist circumference (p < 0.01). 
Postmenopausal women had higher BMI values and 
waist circumferences compared with premenopausal 
women. Overall, perimenopausal symptom scores 
had statistically significant differences by menopause 
status as shown by the Kruskal-Wallis test (p = 0.025), 
whereas the Mann-Whitney U test processed multiple 
comparisons without showing any statistical signifi-
cance (p > 0.017) (pre- vs. peri-, p = 0.027; pre- vs. 
post, p = 0.021; and peri- vs. post, p = 0.98). For the 
five symptom subscales (domains), perimenopausal 
and postmenopausal women were significantly older 
and had higher reproductive symptom scores than 
premenopausal women (p < 0.01). Cardiovascular, os-
teoarthritis, urinary, and psychological symptoms did 
not show significant differences in the three groups 
of menopause states.
3.3. Experience with perimenopausal 
symptoms related to the level of BMI 
and waist circumference
Experience with perimenopausal symptoms was as-
sessed according to the level of BMI and waist cir-
cumference, and the results are presented in Table 3. 
Being older was associated with significant differ-
ences in centrally obese women (waist circumference = 
80 cm) when compared with non-centrally obese 
Table 2 — DPS, BMI, and waist circumferences according to menopausal states (n = 56)*
 Premenopausal (n = 24) Perimenopausal (n = 14) Postmenopausal (n = 18)
Age (yr) 43.08 ± 2.70 48.71 ± 3.64† 51.22 ± 4.94†
BMI (kg/m2) 23.65 (21.65–24.85) 25.50 (23.43–27.82) 25.79 (23.23–30.21)‡
Waist circumference (cm) 74.60 ± 5.4 79.65 ± 6.98 81.57 ± 8.50†
DPS (items) 48.00 (42.25–58.00) 56.50 (49.25–70.50) 57.00 (49.50–65.25)
Cardiovascular/autonomic nervous symptoms (9) 11.83 ± 2.82 13.07 ± 3.83 11.78 ± 4.32
Osteoarthritis symptoms (2) 2.50 (2.00–4.00) 2.50 (2.00–4.00) 4.00 (2.75–4.00)
Urinary symptoms (5) 6.00 (5.00–7.75) 6.00 (5.00–7.75) 6.50 (5.00–8.25)
Reproductive system symptoms (8) 8.50 (8.00–10.00) 12.50 (10.75–16.25)† 12.50 (9.75–16.50)†
Psychological/psychiatric symptoms (14) 19.21 ± 4.64 22.21 ± 6.54 23.00 ± 6.65
*Data presented as mean ± standard deviation or median (Q1–Q3); †significant difference compared with premenopause, two-tailed (p < 0.01); 
‡significant difference compared with premenopause, two-tailed (p < 0.017). DPS = overall disturbance of perimenopausal symptoms; BMI = body 
mass index.
Table 3 — Disturbance of perimenopausal symptoms according to BMI and waist circumference by Mann-Whitney U 
test (n = 56)*
 BMI WC
 Not obese  Obese No central obesity Central obesity
 < 27 (n = 42) ≥ 27 (n = 14) < 80 cm (n = 34) ≥ 80 cm (n = 22)
Age (yr) 46.00 (41.75–50.25) 49.00 (47.75–51.25) 45.00 (40.00–48.00) 49.00 (47.75–53.25)†
DPS 50.50 (44.50–62.00) 56.50 (50–75.25)‡ 50.50 (43.0–62.0) 56.50 (47.75–64.75)
Cardiovascular/autonomic 11.00 (9.00–14.00) 10.50 (9–15.50) 11.50 (9.00–14.00) 10.50 (9.00–13.50)
 nervous symptoms
Osteoarthritis symptoms 3.00 (2.00–4.00) 3.00 (2.00–4.00) 3.00 (2.00–4.00) 3.00 (2.00–4.00)
Urinary symptoms 6.00 (5.00–14.00) 7.00 (6.00–10.00)‡ 6.00 (5.00–7.25) 7.00 (5.00–8.25)
Reproductive system symptoms 10.00 (8.00–14.00) 14.00 (10.50–16.50)‡ 9.50 (8.00–12.25) 13.50 (10.50–16.25)†
Psychological/psychiatric symptoms 20.00 (15.00–23.25) 25.00 (16.75–29.00) 19.50 (14.75–24.00) 21.50 (16.75–28.0)
*Data presented as median (Q1–Q3); 
†p < 0.01, two-tailed; ‡p < 0.05, two-tailed. BMI = body mass index; WC = waist circumference; DPS = overall 
disturbance of perimenopausal symptoms.
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women (waist circumference < 80 cm, p < 0.05), but 
not with obese women (BMI ≥ 27, p = 0.105). Obese 
women had higher overall perimenopausal symptoms 
as well as urinary and reproductive symptom complaint 
scores than non-obese women (p < 0.05). Similarly, 
women with central obesity had higher reproductive 
system complaint scores than non-central obese 
women (p < 0.01). While centrally-obese women had 
higher urinary symptoms scores than non-centrally 
obese women, there were no statistically significant 
differences (p = 0.123).
4. Discussion
According to the categories of BMI for identifying obes-
ity used in this study, 25% of mid-life women were 
obese, with a BMI level at or above 27 kg/m2, indicat-
ing a potential risk of obesity for mid-life women in 
rural communities. Additionally, just under half of the 
women had a waist circumference ≥ 80 cm. The results 
showed an increase with age in body fat mass and cen-
tral distribution of body fat. These findings are similar 
to the results of a study by Douchi et al [24].
Menopause is a process from pre- to peri- to post-
menopausal periods in a woman’s life. Women grad-
ually mature, age, and enter menopause. Brett and 
Cooper found that an increasing BMI was associated 
with being in menopausal transition [25]. Previous 
studies have shown that weight gain is not significantly 
associated with menopausal status [26,27]. However, 
increasing waist and hip circumferences, and central 
distribution of body fat in postmenopausal women has 
been supported by other studies [28].
In this study, the BMI showed significant variance 
with menopausal status. A comparison of postmeno-
pausal women shows that being in postmenopause 
is associated with having a higher BMI and waist 
circumference when compared with premenopause. 
According to data from the International Diabetes 
Federation in 2006, central obesity in Asian and 
Chinese women is defined by a waist circumference 
> 80 cm. Central obesity is one of the important factors 
associated with metabolic syndrome [29]. In this study, 
almost half of the participants had a waist circum-
ference ≥ 80 cm, demonstrating that central obesity 
remains an important concern. Thus, developing a 
protocol to treat or reduce central fat distribution in 
women in the postmenopausal years is required.
This study found that an older age was significantly 
associated with significant differences in centrally 
obese women (waist circumference ≥ 80 cm) compared 
with non-centrally obese women (waist circumfer-
ence < 80 cm), but this relationship was not found in 
obese women (BMI ≥ 27). This shows that age may 
also be a risk factor for central obesity. In particular, 
fat distribution tends to centralize in the body after 
menopause, resulting in an increase of waist circum-
ference with age. Results of the current study indicate 
that increased central fat distribution in the body with 
age is a concern for menopausal women [27].
Previous studies have concluded that the rate of 
obesity associated with a higher BMI, increases with 
age [6,30]. In our study, obese women were older than 
non-obese women, but this was not statistically sig-
nificant (p = 0.052), although it was a strong trend. The 
reason for this finding might be that the sample size 
was too small to show a significant difference. Never-
theless, it is important that BMI levels be measured 
and matched with measurements of waist circum-
ference when assessing the obesity status of mid-life 
women. It is very easy for people to measure waist 
girth. Nurses could teach women how to measure waist 
girth to track a change in their weight over time.
The menopausal transition leads to the presenta-
tion of a series of clinical signs and symptoms due to 
progressive estrogen deficiency [2,3]. This study vali-
dated previous findings that women in the postmen-
opausal years had higher levels of perimenopausal 
symptoms than those in peri- and premenopause [31]. 
In this study, only reproductive system symptoms had 
a statistically significant difference among the three 
groups (pre-, peri-, and postmenopausal). Similarly, 
obese women had more frequent complaints of over-
all perimenopausal symptoms and higher urinary and 
reproductive system complaint scores than non-obese 
women. Women in postmenopause presented with 
reproductive system symptoms such as vaginal itch-
ing (22.3%), vaginal dryness (55.6%), dyspareunia 
(44.5%) and decline in sexual interest (94.5%) (data 
not shown). Similar results were found by Malacara 
et al [32]. Declining estrogen levels begin at the time 
of menopause and thereafter result in atrophic vagin-
itis. This can lead to vaginal dryness and dyspareunia 
[33]. Furthermore, we found that women with these 
reproductive system symptoms also tended to be 
obese.
Here, we found that women with a higher BMI and 
waist circumference reported more frequent urinary 
symptom complaints. This result is consistent with 
previous findings [34–36]. However, differentiating be-
tween symptoms that are genuinely hormone-related 
(menopause-related) and those that are age-related is 
difficult. The results also indicated that obese post-
menopausal women (BMI ≥ 27) had urinary symptoms 
such as nocturia (50%); incontinence (50%), and when 
coughing, laughing, or lifting heavy weights; frequent 
micturition (37.5%); and urgency (37.5%) (data not 
shown). These findings suggest that interventions 
targeted to relieve urinary symptoms experienced by 
postmenopausal obese women are required.
Evidence has indicated that menopausal women 
are likely to become obese due to menopausal transi-
tion or an increase in age. Women in postmenopause 
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report higher BMI levels and have significant central 
body fat distribution. Therefore, it is suggested that 
Taiwan’s perimenopausal women should measure 
waist circumference and BMI to assess obesity states.
Our participants reported more frequent urinary 
problems in postmenopause and with higher 
BMI levels. The findings suggest that clinical practi-
tioners should develop strategies to reduce BMI for 
menopausal women. Future studies are required to 
determine if women can lose weight to relieve peri-
menopausal symptoms.
An inherent limitation of any study in which the 
participants are volunteers is the potential for non-
response bias. There may be different perceptions of 
perimenopausal symptoms between respondents and 
non-respondents. Unfortunately, there was no way to 
compare the BMI and premenopausal symptoms of 
the respondents and non-respondents in this study. 
The study participants were restricted to those in a 
rural community who volunteered to participate; this 
limited the representativeness of the sample for gen-
eralization to other mid-life women. Another limita-
tion of this study was not considering other variables 
(e.g. number of births and employment) that may 
have influenced study outcomes.
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